Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Nov 12, 2025
Open Peer Review Period: Nov 12, 2025 - Jan 7, 2026
Date Accepted: Mar 31, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

User-Centered Design for Digital Patient-Navigation Tools in Oncology: Scoping Review

Kheirinejad S, White BM, Kheirkhah Rahimabad P, Zink JA, Hashtarkhani S, Kumsa FA, Rashid R, Chinthala L, Brett CL, Davis RL, Schwartz DL, Shaban-Nejad A

User-Centered Design for Digital Patient-Navigation Tools in Oncology: Scoping Review

JMIR Hum Factors 2026;13:e87686

DOI: 10.2196/87686

PMID: 42055540

User-Centered Design for Digital Patient-Navigation Tools in Oncology: A Scoping Review

  • Saba Kheirinejad; 
  • Brianna M. White; 
  • Parnian Kheirkhah Rahimabad; 
  • Janet A. Zink; 
  • Soheil Hashtarkhani; 
  • Fekede Asefa Kumsa; 
  • Rezaur Rashid; 
  • Lokesh Chinthala; 
  • Christopher L. Brett; 
  • Robert L. Davis; 
  • David L. Schwartz; 
  • Arash Shaban-Nejad

ABSTRACT

Background:

Cancer patient navigation programs improve access and continuity of care, yet their digital transformation often suffers from poor usability and limited uptake. Applying user-centered and human-centered design (UCD/HCD) principles may close this gap, but the extent to which such methods are used and evaluated in oncology navigation tools remains unclear.

Objective:

This scoping review identifies how user-centered and human-centered design principles have been, and should be, applied in developing and implementing digital health tools for cancer patient navigation.

Methods:

A scoping review was conducted following PRISMA-ScR and Joanna Briggs Institute guidance. Seven databases (PubMed/MEDLINE, Scopus, IEEE Xplore, Web of Science, Embase, ACM Digital Library, CINAHL) were searched for English-language articles published between January 2015 and July 2025. Eligible studies reported original, peer-reviewed research on digital or mHealth interventions linked to cancer navigation and documented at least one UCD/HCD activity. Two reviewers independently screened records and charted data on context, target users, functions, tool modality, design stage, methods, and outcomes. Findings were synthesized descriptively and thematically.

Results:

36 studies met the inclusion criteria. Findings were organized into four domains: study characteristics, navigation functions and modalities, design processes, and UCD/HCD application. Iterative prototyping and usability testing were most common, while participatory design and implementation evaluation were underutilized.

Conclusions:

UCD/HCD approaches enhance usability and patient relevance of digital cancer navigation tools. However, their application remains limited across cancer types, regions, and functions. Broader stakeholder participation and evaluation beyond usability are needed to strengthen coordination, equity, and sustainability in cancer care.


 Citation

Please cite as:

Kheirinejad S, White BM, Kheirkhah Rahimabad P, Zink JA, Hashtarkhani S, Kumsa FA, Rashid R, Chinthala L, Brett CL, Davis RL, Schwartz DL, Shaban-Nejad A

User-Centered Design for Digital Patient-Navigation Tools in Oncology: Scoping Review

JMIR Hum Factors 2026;13:e87686

DOI: 10.2196/87686

PMID: 42055540

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.